rs2230688
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001379500.1(COL18A1):c.846G>T(p.Thr282Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,613,426 control chromosomes in the GnomAD database, including 15,414 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.18 ( 3315 hom., cov: 33)
Exomes 𝑓: 0.12 ( 12099 hom. )
Consequence
COL18A1
NM_001379500.1 synonymous
NM_001379500.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.148
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 21-45476398-G-T is Benign according to our data. Variant chr21-45476398-G-T is described in ClinVar as [Benign]. Clinvar id is 261887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-45476398-G-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.148 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.329 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL18A1 | NM_001379500.1 | c.846G>T | p.Thr282Thr | synonymous_variant | 6/42 | ENST00000651438.1 | NP_001366429.1 | |
COL18A1 | NM_130444.3 | c.2091G>T | p.Thr697Thr | synonymous_variant | 5/41 | NP_569711.2 | ||
COL18A1 | NM_030582.4 | c.1386G>T | p.Thr462Thr | synonymous_variant | 5/41 | NP_085059.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL18A1 | ENST00000651438.1 | c.846G>T | p.Thr282Thr | synonymous_variant | 6/42 | NM_001379500.1 | ENSP00000498485.1 | |||
COL18A1 | ENST00000355480.10 | c.1386G>T | p.Thr462Thr | synonymous_variant | 5/41 | 1 | ENSP00000347665.5 | |||
COL18A1 | ENST00000359759.8 | c.2091G>T | p.Thr697Thr | synonymous_variant | 5/41 | 5 | ENSP00000352798.4 |
Frequencies
GnomAD3 genomes AF: 0.179 AC: 27177AN: 151934Hom.: 3308 Cov.: 33
GnomAD3 genomes
AF:
AC:
27177
AN:
151934
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.142 AC: 35205AN: 247142Hom.: 3111 AF XY: 0.140 AC XY: 18774AN XY: 134564
GnomAD3 exomes
AF:
AC:
35205
AN:
247142
Hom.:
AF XY:
AC XY:
18774
AN XY:
134564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.115 AC: 168310AN: 1461372Hom.: 12099 Cov.: 33 AF XY: 0.116 AC XY: 84268AN XY: 726968
GnomAD4 exome
AF:
AC:
168310
AN:
1461372
Hom.:
Cov.:
33
AF XY:
AC XY:
84268
AN XY:
726968
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.179 AC: 27217AN: 152054Hom.: 3315 Cov.: 33 AF XY: 0.181 AC XY: 13453AN XY: 74348
GnomAD4 genome
AF:
AC:
27217
AN:
152054
Hom.:
Cov.:
33
AF XY:
AC XY:
13453
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Knobloch syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at